首页> 外文期刊>BMC Cancer >Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis
【24h】

Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis

机译:Fogo Stage IB2 / IIA2宫颈癌各种疗法的有效性比较:贝叶斯网络Meta分析

获取原文
       

摘要

Cervical cancer is a common malignancy of the female genital tract. Treatment options for cervical cancer patients diagnosed at FIGO (2009) stage IB2 and IIA2 remains controversial. We perform a Bayesian network meta-analysis to directly or indirectly compare various interventions for FIGO (2009) IB2 and IIA2 disease, in order to improve our understand of the optimal treatment strategy for these women. Three databases were searched for articles published between 1971 and 2020. Data on included study characteristics, outcomes, and risk of bias were abstracted by two reviewers. Seven thousand four hundred eighty-six articles were identified. Thirteen randomized controlled trials of FIGO (2009) IB2 and IIA2 cervical cancer patients were included in the final analysis. These trials used six different interventions: concomitant chemoradiotherapy (CCRT), radical surgery (RS), radical surgery following chemoradiotherapy (CCRT+RS), neoadjuvant chemotherapy followed by radical surgery (NACT+RS), adjuvant radiotherapy followed by Radical surgery (RT?+?RS), radiotherapy alone (RT).SUCRA ranking of OS and Relapse identified CCRT+RS and CCRT as the best interventions, respectively. Systematic clustering analysis identified the CCRT group as a unique cluster. These data suggest that CCRT may be the best approach for improving the clinical outcome of cervical cancer patients diagnosed at FIGO (2009) stage IB2/IIA2. Phase III randomized trials should be performed in order to robustly assess the relative efficacy of available treatment strategies in this disease context.
机译:宫颈癌是女性生殖道的常见恶性肿瘤。诊断为FIGO(2009)阶段IB2和IIA2诊断的宫颈癌患者的治疗方案仍存在争议。我们执行贝叶斯网络元分析,直接或间接地比较Figo(2009)IB2和IIA2疾病的各种干预,以改善我们对这些妇女的最佳治疗策略。搜索了1971年至2020年间发布的文章的三个数据库。由两名审查员提出了关于包括研究特征,结果和偏见风险的数据。确定了七千四百八十六篇文章。终点分析中包括十三(2009)IB2和IIA2宫颈癌患者的十三次随机对照试验。这些试验使用了六种不同的干预:伴随化学疗法(CCRT),自由基手术(RS),细化学疗法(CCRT + RS),新辅助化疗,后跟自由基手术(NACT + RS),佐剂放射疗法,然后是自由基手术(RT? +?RS),单独放射治疗(RT)。Sucra排名的操作系统和复发鉴定了CCRT + Rs和CCRT作为最佳干预措施。系统聚类分析将CCRT组标识为唯一群集。这些数据表明,CCRT可能是改善诊断为Figo(2009)阶段IA2 / IIA2的宫颈癌患者临床结果的最佳方法。应进行III期随机试验,以鲁布利地评估可用治疗策略在该疾病环境中的相对疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号